Publication: The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria
Issued Date
2006-12-01
Resource Type
ISSN
00316970
Other identifier(s)
2-s2.0-33751206523
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
European Journal of Clinical Pharmacology. Vol.62, No.12 (2006), 1003-1009
Suggested Citation
Paul N. Newton, Karen I. Barnes, Peter J. Smith, Alicia C. Evans, Wirongrong Chierakul, Ronatrai Ruangveerayuth, Nicholas J. White The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. European Journal of Clinical Pharmacology. Vol.62, No.12 (2006), 1003-1009. doi:10.1007/s00228-006-0203-2 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/23461
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria
Other Contributor(s)
Abstract
Objective: Intravenous artesunate is commonly used in the emergency treatment of patients with severe falciparum malaria in Asia. The choice of doses used has been empirical. To inform dosage recommendations we assessed the pharmacokinetics of intravenous artesunate after the first dose. Methods: As part of a clinical trial of artesunate in adults with severe falciparum malaria in western Thailand, we assayed plasma concentrations of artesunate and the principal biologically active metabolite dihydroartemisinin (DHA) in 17 patients given an initial dose of 2.4 mg/kg body weight of intravenous artesunate. Drug levels were measured using high performance liquid chromatography with mass spectroscopy-electrospray ionisation detection. Results: Median (range) observed DHA Cmax was 2128 (513-5789) nmol/L, elimination half-life was 0.34 (0.14-0.87) h, and the time to the last detectable DHA was 2 h. Conclusion: The large inter-individual variability (10 fold) in DHA Cmax and AUC in patients with potentially lethal, severe malaria, suggests that 2.4 mg/kg should be the minimum daily dose in severe malaria. © 2006 Springer-Verlag.